发明名称 |
USE OF PEMIROLAST |
摘要 |
According to the invention there is provided a method for the treatment of airway hyperresponsiveness, which method comprises the administration of pemirolast, or a pharmaceutically acceptable salt thereof, to a patient in need of such treatment. Suitable lower doses of pemirolast are least about 110 mg per day. |
申请公布号 |
US2017112837(A1) |
申请公布日期 |
2017.04.27 |
申请号 |
US201615136519 |
申请日期 |
2016.04.22 |
申请人 |
RSPR Pharma AB |
发明人 |
RAUD Johan;DALSGAARD Carl-Johan;TORNLING Goran |
分类号 |
A61K31/519;A61K45/06 |
主分类号 |
A61K31/519 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for the treatment of airway hyperresponsiveness in a paediatric patient, which method comprises administering pemirolast, or a pharmaceutically acceptable salt thereof, to a human patient of an age that is up to about 24 months and having a condition characterized by airway hyperresponsiveness, wherein said administering is carried out by orally administering a dose effective to reduce airway hyperresponsiveness, which dose is at least about 25 mg per day. |
地址 |
Stockholm SE |